Trademark Details For R² (Serial Number 88655182)

  •  Home
  •  Print
R²
7
6
4
0
Serial Number  United States - USPTO 88655182
Registration Number 6042656
Mark
Filing Date Oct-15-2019
Status
Registered  
SECTION 8 & .. (702)
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
Attorney Name
TTAB
0



  • Description Of Mark:
  • Color(s) Claimed:

005Pharmaceuticals

U.S Class(es): 006, 018, 044, 046, 051, 052

Class Status: Active

First Use: May-28-2019

First Use in Commerce: May-28-2019

044Medical, beauty and agricultural

U.S Class(es): 100, 101

Class Status: Active

First Use: May-28-2019

First Use in Commerce: May-28-2019





Correspondences

NameMarilyn F. Kelly Bristol-Myers Squibb Company
AddressPO BOX 4000 Trademark Dept., Mailstop D.4243 PRINCETON, NJ 08648 United States

Prosecution History

DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Oct-18-2019NEW APPLICATION ENTERED   NWAPI
Oct-18-2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Dec-30-2019ASSIGNED TO EXAMINER   DOCKD
Jan-06-2020APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Jan-22-2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Feb-11-2020PUBLISHED FOR OPPOSITION   PUBOA
Feb-11-2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Apr-28-2020REGISTERED-PRINCIPAL REGISTER   R.PRA
Dec-09-2022TEAS CHANGE OF OWNER ADDRESS RECEIVED   COARI
Dec-09-2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED   REAPI
Dec-09-2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED   ARAAI
Dec-09-2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS   EWAFI
Dec-09-2022TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
Dec-09-2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED   CHANI
Apr-28-2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED   REM1E
Jan-16-2026TEAS SECTION 8 & 15 RECEIVED   E815I
Apr-10-2026CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Apr-10-2026REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.   C15AO
Apr-10-2026NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED   NA85E